Glenmark Pharma to raise up to $200 million

INSUBCONTINENT EXCLUSIVE:
glenmark pharmaceuticals: Glenmark Pharma to raise up to $200 million - The TheIndianSubcontinentNever miss a great news story!Get instant
notifications from TheIndianSubcontinentAllowNot nowYou can switch off notifications anytime using browser settings.NewsStock Analysis, IPO,
Mutual Funds, Bonds - MoreThe proposal was approved at the company's annual general meeting held on September 27
PTI|Sep 28, 2019, 03.44 PM ISTGetty ImagesThe price at which the debt securities will be issued shall be determined by the board in
accordance with applicable laws and consultation with appropriate advisors, it added
Glenmark Pharmaceuticals on Saturday said its shareholders have approved a proposal to raise up to $200 million (about Rs 1,413 crore)
through issuance of debt securities
The proposal was approved at the company's annual general meeting held on September 27
"All the Resolutions were declared passed with the requisite majority," the company said in a BSE filing
According to the proposal, the firm plans to raise up to $200 million in Indian and/or international market through bonds, debentures or
other debt securities in one or more tranches
The price at which the debt securities will be issued shall be determined by the board in accordance with applicable laws and consultation
with appropriate advisors, it added. Commenting feature is disabled in your country/region.Browse
CompaniesABCDEFGHIJKLMNOPQRSTUVWXYZ|123456789To see your saved stories, click on link hightlighted in bold